首页|电针联合米非司酮治疗子宫腺肌症痛经疗效观察

电针联合米非司酮治疗子宫腺肌症痛经疗效观察

扫码查看
目的 观察电针联合米非司酮治疗子宫腺肌症痛经(AD)的疗效.方法 将我院140例AD患者随机分为对照组与观察组各70例.对照组口服米非司酮治疗,观察组给予电针和口服米非司酮治疗.比较两组临床疗效、白介素-6(IL-6)、前列腺素F2α(PGF2α)、β-内啡肽(B-EP)、糖类抗原125(CA125)、糖类抗原199(CA199)、子宫内膜厚度、子宫体积、痛经视觉模拟评分(VAS)、月经失血图法(PBAC)、COX痛经症状评估量表(CMSS)、雌二醇(E2)、促黄体生成素(LH)、卵泡刺激素(FSH)及复发率.结果 治疗后,观察组总有效率高于对照组(P<0.05);两组IL-6、PGF2α、CA125、CA199水平低于治疗前,B-EP水平高于治疗前;观察组IL-6、PGF2α、CA125、CA199水平低于对照组,B-EP水平高于对照组(P<0.05);两组子宫内膜厚度、子宫体积、VAS、PBAC、CMSS低于治疗前,观察组上述指标低于对照组(P<0.05);两组E2、LH、FSH水平低于治疗前,观察组上述指标低于对照组(P<0.05);观察组复发率低于对照组(P<0.05).结论 电针联合米非司酮提高治疗AD的疗效,改善子宫的结构,减轻痛经程度,降低炎症,调节性激素和相关因子水平,减少复发.
Effect observation on electroacupuncture combined with mifepristone on dysmenorrhea caused by adenomyosis
Objective To observe the efficacy of electroacupuncture(EA)combined with mifepristone in treatment of dysmenorrhea(AD)in adenomyosis.Methods A total of 140 AD patients were randomly divided into control group and ob-servation group with 70 cases in each group.Control group was given oral mifepristone,and observation group was given EA on the basis of control group.The clinical efficacy,interleukin-6(IL-6),prostaglandin F2α(PGF2α),β-endorphins(β-EP),carbohydrate antigen 125(CA125),carbohydrate antigen 199(CA199),endometrial thickness,uterine volume,Visual Analogue Scale(VAS)score,menstrual blood loss chart(PBAC),COX Dysmenorrhea Symptom Assessment Scale(CMSS),estradiol(E2),luteinizing hormone(LH),follicle-stimulating hormone(FSH)levels,and the recurrence rate of the two groups were compared.Results After treatment,the total effective rate of observation group was higher than that of control group(P<0.05);IL-6,PGF2α,CA125 and CA199 levels in both groups were lower than those before treatment,while B-EP levels were higher,the above indicators were superior in observation group to those in control group(P<0.05);endometrial thickness,uterine volume,VAS,PBAC,and CMSS scores in both groups were lower than those before treatment,and were lower in observation group than control group(P<0.05);E2,LH and FSH levels in both groups were lower than those before treatment,and were lower in observation group than control group(P<0.05);the recurrence rate of observation group was lower than that of control group(P<0.05).Conclusion EA combined with mifepristone can improve the efficacy of AD,improve the structure of the uterus,reduce the degree of dysmenorrhea,reduce inflammation,regulate the levels of sex hormones and related factors.and reduce recurrence.

AdenomyosisDysmenorrheaElectroacupunctureMifepristone

杨文静、田勇

展开 >

湖北省恩施土家族苗族自治州中心医院,湖北恩施 445000

子宫腺肌症 痛经 电针 米非司酮

湖北省中医药科研立项项目

ZY2023F119

2024

湖北中医药大学学报
湖北中医药大学

湖北中医药大学学报

CSTPCD
影响因子:0.873
ISSN:1008-987X
年,卷(期):2024.26(5)
  • 17